Clinical Use of Antidepressant Blood Levels and the Electrocardiogram

Publisher Website
Google Scholar
Abstract
The introduction of sensitive laboratory assays for the analysis of cyclic antidepressant blood levels more than 15 years ago promised a rational basis for drug treatment of serious depressive illness. Early studies demonstrated a linear or sigmoid relation between the blood level of imipramine and the therapeutic response. For nortriptyline, a curvilinear inverted U, the so-called therapeutic window, was established. In other studies of patients who had taken overdoses of antidepressants, blood levels also correlated well with cardiac toxicity: all patients with blood levels above 1000 ng per milliliter had a QRS of more than 100 msec. Unfortunately, in recent . . .